Stay updated on ARGX-110 in Advanced Malignancies Clinical Trial
Sign up to get notified when there's something new on the ARGX-110 in Advanced Malignancies Clinical Trial page.

Latest updates to the ARGX-110 in Advanced Malignancies Clinical Trial page
- ChecktodayChange DetectedA notice was added above the 403 page announcing NIH’s terminology transition from “Artificial Intelligence” to “Super Intelligence.”SummaryDifference1%

- Check7 days agoChange DetectedThe footer revision identifier changes from v3.7.1 to v3.7.2 while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check14 days agoChange DetectedThe footer revision identifier changes from v3.7.0 to v3.7.1; the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check35 days agoChange DetectedThe study page now displays a 403 Forbidden error, indicating that the record is inaccessible and no trial details can be viewed from this page.SummaryDifference18%

- Check56 days agoChange DetectedNew page revision displayed as Revision: v3.6.6 replaces the previous v3.6.5, signaling a minor update to the page’s revision history. This change does not modify the study data, content, or functionality.SummaryDifference0.1%

- Check78 days agoChange DetectedThe revision label at the bottom of the page was updated to v3.6.5, representing a small template or backend update.SummaryDifference0.1%

Stay in the know with updates to ARGX-110 in Advanced Malignancies Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ARGX-110 in Advanced Malignancies Clinical Trial page.